Literature DB >> 20671751

China spurs pharma innovation.

Bethan Hughes.   

Abstract

Mesh：

Year:  2010        PMID： 20671751     DOI： 10.1038/nrd3238

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Evolving R&D for emerging markets.

Authors: 
Journal:  Nat Rev Drug Discov       Date:  2010-06       Impact factor: 84.694
  1 in total
  3 in total

1.  Public funding and private investment for R&D: a survey in China's pharmaceutical industry.

Authors:  Lan Qiu; Zi-Ya Chen; Deng-Yu Lu; Hao Hu; Yi-Tao Wang
Journal:  Health Res Policy Syst       Date:  2014-06-13

2.  Contract Research Organizations (CROs) in China: integrating Chinese research and development capabilities for global drug innovation.

Authors:  Yun-Zhen Shi; Hao Hu; Chunming Wang
Journal:  Global Health       Date:  2014-11-19       Impact factor: 4.185

3.  Bioinformatics and the Politics of Innovation in the Life Sciences: Science and the State in the United Kingdom, China, and India.

Authors:  Brian Salter; Yinhua Zhou; Saheli Datta; Charlotte Salter
Journal:  Sci Technol Human Values       Date:  2016-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.